Skip to main content

Jensten finds buyer in Bain Capital

Rob Organ

Jensten is set to be bought by private equity firm Bain Capital, following two years of attempts to find a buyer.

The transaction is expected to close in the final quarter of 2025, subject to regulatory approvals. Terms of the sale were not disclosed.

According to the announcement, Bain will “partner closely” with

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Q&A: Chris Jolley and Jeff Mountford, WHO2 Global

WHO2 Global co-founders Chris Jolley, CEO, and Jeff Mountford, chief technology officer, reveal how the start-up’s Benchmarq360 uses data, artificial intelligence, and experience to improve the way insurers work.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here